Meng Q - Search Results

1

Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.

Liang C, Shi S, Qin Y, Meng Q, Hua J, Hu Q, Ji S, Zhang B, Xu J, Yu XJ. Liang C, et al. Among authors: meng q. Gut. 2020 May;69(5):888-900. doi: 10.1136/gutjnl-2018-317163. Epub 2019 Oct 14. Gut. 2020. PMID: 31611300 Review.

2

A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.

Liu W, Zhang B, Hu Q, Qin Y, Xu W, Shi S, Liang C, Meng Q, Xiang J, Liang D, Ji S, Liu J, Hu P, Liu L, Liu C, Long J, Ni Q, Yu X, Xu J. Liu W, et al. Among authors: meng q. Int J Oncol. 2017 May;50(5):1792-1800. doi: 10.3892/ijo.2017.3938. Epub 2017 Mar 28. Int J Oncol. 2017. PMID: 28350132

3

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis.

Meng Q, Shi S, Liang C, Liang D, Xu W, Ji S, Zhang B, Ni Q, Xu J, Yu X. Meng Q, et al. Onco Targets Ther. 2017 Sep 15;10:4591-4598. doi: 10.2147/OTT.S145708. eCollection 2017. Onco Targets Ther. 2017. PMID: 28979147 Free PMC article. Review.

4

Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?

Liang C, Shi S, Meng Q, Liang D, Ji S, Zhang B, Qin Y, Xu J, Ni Q, Yu X. Liang C, et al. Among authors: meng q. Cell Mol Life Sci. 2018 Mar;75(6):1001-1012. doi: 10.1007/s00018-017-2678-7. Epub 2017 Oct 9. Cell Mol Life Sci. 2018. PMID: 28993833 Free PMC article. Review.

5

Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Meng Q, Shi S, Liang C, Xiang J, Liang D, Zhang B, Qin Y, Ji S, Xu W, Xu J, Ni Q, Yu X. Meng Q, et al. J Cancer. 2017 Oct 9;8(17):3615-3622. doi: 10.7150/jca.18901. eCollection 2017. J Cancer. 2017. PMID: 29151947 Free PMC article.

6

Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.

Shi S, Hua J, Liang C, Meng Q, Liang D, Xu J, Ni Q, Yu X. Shi S, et al. Among authors: meng q. Ann Surg. 2019 May;269(5):944-950. doi: 10.1097/SLA.0000000000002668. Ann Surg. 2019. PMID: 29334560

7

Mismatch repair status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for pancreatic cancer.

Liang D, Shi S, Liang C, Meng Q, Zhang B, Ni Q, Xu J, Yu X. Liang D, et al. Among authors: meng q. Surgery. 2018 May;163(5):1080-1089. doi: 10.1016/j.surg.2017.12.009. Epub 2018 Jan 17. Surgery. 2018. PMID: 29352574

8

TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer.

Xiang J, Hu Q, Qin Y, Ji S, Xu W, Liu W, Shi S, Liang C, Liu J, Meng Q, Liang D, Ni Q, Xu J, Zhang B, Yu X. Xiang J, et al. Among authors: meng q. Cell Death Dis. 2018 Feb 23;9(3):321. doi: 10.1038/s41419-018-0367-6. Cell Death Dis. 2018. PMID: 29476053 Free PMC article.

9

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going.

Liang C, Shi S, Meng Q, Liang D, Ji S, Zhang B, Qin Y, Xu J, Ni Q, Yu X. Liang C, et al. Among authors: meng q. Exp Mol Med. 2017 Dec 1;49(12):e406. doi: 10.1038/emm.2017.255. Exp Mol Med. 2017. PMID: 29611542 Free PMC article. Review.

10

MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125.

Liang C, Shi S, Meng Q, Liang D, Hua J, Qin Y, Zhang B, Xu J, Ni Q, Yu X. Liang C, et al. Among authors: meng q. Int J Cancer. 2018 Dec 1;143(11):2919-2931. doi: 10.1002/ijc.31654. Epub 2018 Sep 29. Int J Cancer. 2018. PMID: 29978477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,532 results

Search Page

Filters